These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
|
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
|
Commission file
number |
Exact name of registrant as
specified in its charter |
IRS Employer
Identification No. |
State or other jurisdiction of
incorporation or organization |
|||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
|
|
|
|
||||||||||||
| Large Accelerated Filer | ☐ |
|
☒ | Non-accelerated filer | ☐ | Smaller reporting company |
|
Emerging growth company |
|
||||||||||||||||||||
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
☐ | ||||||||||||||||||||||||||||
|
|
Page | |||||||||||||
|
Condensed
Consolidated and Combined Balance Sheets
|
||||||||||||||
| Item 1 | ||||||||||||||
| Item 1A | ||||||||||||||
| Quarterly Period Ended | Two Quarterly Periods Ended | ||||||||||||||||||||||||||||||||||
|
(in millions of dollars, except per share amounts)
|
March 29, 2025 | March 30, 2024 | March 29, 2025 | March 30, 2024 | |||||||||||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Costs and expenses: | |||||||||||||||||||||||||||||||||||
| Cost of goods sold |
|
|
|
|
|||||||||||||||||||||||||||||||
| Selling, general and administrative |
|
|
|
|
|||||||||||||||||||||||||||||||
| Amortization of intangibles |
|
|
|
|
|||||||||||||||||||||||||||||||
| Transaction and other activities |
|
|
|
|
|||||||||||||||||||||||||||||||
| Corporate expense allocation |
|
|
|
|
|||||||||||||||||||||||||||||||
| Operating income (loss) |
|
|
(
|
|
|||||||||||||||||||||||||||||||
| Other expense (income), net |
|
|
|
(
|
|||||||||||||||||||||||||||||||
| Interest expense |
|
|
|
|
|||||||||||||||||||||||||||||||
| Income (loss) before income taxes |
(
|
|
(
|
|
|||||||||||||||||||||||||||||||
| Income tax benefit |
|
|
(
|
|
|||||||||||||||||||||||||||||||
| Net income (loss) | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Net income (loss) per share: | |||||||||||||||||||||||||||||||||||
| Basic and Diluted |
(
|
|
(
|
|
|||||||||||||||||||||||||||||||
| Quarterly Period Ended | Two Quarterly Periods Ended | ||||||||||||||||||||||||||||||||||
|
(in millions of dollars)
|
March 29, 2025 | March 30, 2024 | March 29, 2025 | March 30, 2024 | |||||||||||||||||||||||||||||||
| Net income (loss) | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Other comprehensive income, net of tax: | |||||||||||||||||||||||||||||||||||
| Currency translation gain (loss) |
|
(
|
(
|
|
|||||||||||||||||||||||||||||||
| Other comprehensive income (loss) |
|
(
|
(
|
|
|||||||||||||||||||||||||||||||
| Comprehensive income (loss) | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
|
(in millions of dollars)
|
March 29, 2025 | September 28, 2024 | |||||||||
| Assets |
(Unaudited)
|
||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
|
Accounts receivable
|
|
|
|||||||||
|
Finished goods
|
|
|
|||||||||
|
Raw materials
|
|
|
|||||||||
| Prepaid expenses and other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
|
Noncurrent assets:
|
|||||||||||
|
Property, plant and equipment
|
|
|
|||||||||
|
Goodwill and intangible assets
|
|
|
|||||||||
| Right-of-use assets |
|
|
|||||||||
| Other assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| Liabilities and stockholders’ equity | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ |
|
$ |
|
|||||||
| Accrued expenses |
|
|
|||||||||
| Current portion of long-term debt |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
|
Noncurrent liabilities:
|
|||||||||||
| Long-term debt |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Operating lease liabilities |
|
|
|||||||||
| Other long-term liabilities |
|
|
|||||||||
| Total liabilities |
|
|
|||||||||
| Stockholders’ equity: | |||||||||||
|
Berry net investment
|
|
|
|||||||||
| Additional paid-in capital |
|
|
|||||||||
|
Retained loss
|
(
|
|
|||||||||
| Accumulated other comprehensive loss |
(
|
(
|
|||||||||
| Total stockholders’ equity |
|
|
|||||||||
| Total liabilities and stockholders’ equity | $ |
|
$ |
|
|||||||
| Two Quarterly Periods Ended | |||||||||||
|
(in millions of dollars)
|
March 29, 2025 | March 30, 2024 | |||||||||
| Cash Flows from Operating Activities: | |||||||||||
| Net income (loss) | $ |
(
|
$ |
|
|||||||
| Adjustments to reconcile net cash from operating activities: | |||||||||||
| Depreciation |
|
|
|||||||||
| Amortization of intangibles |
|
|
|||||||||
| Non-cash interest expense |
|
|
|||||||||
| Deferred income tax |
|
|
|||||||||
| Share-based compensation expense |
|
|
|||||||||
| Other non-cash operating activities, net |
|
|
|||||||||
| Changes in working capital, net |
(
|
(
|
|||||||||
| Change in other assets and liabilities |
|
|
|||||||||
| Net cash from (used in) operating activities |
|
(
|
|||||||||
| Cash Flows from Investing Activities: | |||||||||||
| Additions to property, plant and equipment, net |
(
|
(
|
|||||||||
| Cash acquired from GLT acquisition |
|
|
|||||||||
| Settlement of net investment hedges |
|
|
|||||||||
| Other investing activities and other |
|
|
|||||||||
| Net cash from (used in) investing activities |
|
(
|
|||||||||
| Cash Flows from Financing Activities: | |||||||||||
| Proceeds from long-term borrowings |
|
|
|||||||||
| Repayments on long-term borrowings |
(
|
(
|
|||||||||
| Transfers from (to) Berry, net |
|
|
|||||||||
| Cash distribution to Berry |
(
|
|
|||||||||
| Debt fees |
(
|
|
|||||||||
| Net cash from financing activities |
|
|
|||||||||
| Effect of currency translation on cash |
(
|
|
|||||||||
| Net change in cash and cash equivalents |
|
(
|
|||||||||
| Cash and cash equivalents at beginning of period |
|
|
|||||||||
| Cash and cash equivalents at the end of period | $ |
|
$ |
|
|||||||
|
(in millions of dollars)
|
|||||||||||||||||
| Quarterly Period Ended |
Berry
Net Investment
|
Additional
Paid-in Capital
|
Other Comprehensive Income (Loss) - Currency Translation
|
Retained
Loss
|
Total Stockholders’ Equity
|
||||||||||||
| Balance at December 28, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||
| Net loss | — | — | — |
(
|
(
|
||||||||||||
| Other comprehensive income (loss) | — | — |
|
— |
|
||||||||||||
| Share-based compensation | — |
|
— | — |
|
||||||||||||
| Other | — |
(
|
— | — |
(
|
||||||||||||
| Balance at March 29, 2025 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||
| Balance at December 30, 2023 | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||
| Net income |
|
— | — | — |
|
||||||||||||
| Other comprehensive income (loss) | — | — |
(
|
— |
(
|
||||||||||||
| Transfers from parent, net |
|
— | — | — |
|
||||||||||||
| Balance at March 30, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||
| Two Quarterly Periods Ended |
Berry
Net Investment
|
Additional
Paid-in Capital
|
Other Comprehensive Income (Loss) - Currency Translation
|
Retained
Loss
|
Total Stockholders’ Equity
|
||||||||||||
| Balance at September 28, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||
| Net loss | — | — | — |
(
|
(
|
||||||||||||
| Other comprehensive income (loss) | — | — |
(
|
— |
(
|
||||||||||||
| Transfers to Berry, net |
(
|
— | — | — |
(
|
||||||||||||
| October net investment |
|
— | — | — |
|
||||||||||||
| Distribution of Berry’s net investment |
(
|
|
— | — |
|
||||||||||||
| Acquisition of GLT | — |
|
— | — |
|
||||||||||||
| Share-based compensation | — |
|
— | — |
|
||||||||||||
| Other | — |
(
|
— | — |
(
|
||||||||||||
| Balance at March 29, 2025 | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||
| Balance at September 30, 2023 | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||
| Net income |
|
— | — | — |
|
||||||||||||
| Other comprehensive income (loss) | — | — |
|
— |
|
||||||||||||
| Transfers from parent, net |
|
— | — | — |
|
||||||||||||
| Balance at March 30, 2024 | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
|||||||
|
Fair value of GLT common stock concurrent with closing
|
$ |
|
|||
| Identifiable assets acquired and liabilities assumed | |||||
| Cash |
|
||||
|
Working capital
(a)
|
|
||||
| Property, plant and equipment |
|
||||
| Identifiable intangible assets |
|
||||
| Other assets |
|
||||
| Other long-term liabilities |
(
|
||||
| Debt |
(
|
||||
| Goodwill |
|
||||
| Total consideration | $ |
|
|||
| Quarterly Period Ended | Two Quarterly Periods Ended | ||||||||||||||||||||||
| March 29, 2025 | March 30, 2024 | March 29, 2025 | March 30, 2024 | ||||||||||||||||||||
| Americas | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Rest of World |
|
|
|
|
|||||||||||||||||||
| Consolidated | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Employee Severance and Benefits (a)
|
Transaction Activities (b)
|
Non-cash Charges | Other Activities | Total | |||||||||||||||||||||||||
| Balance at September 28, 2024 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Charges |
|
|
|
|
|
||||||||||||||||||||||||
| Non-cash items |
|
|
(
|
|
(
|
||||||||||||||||||||||||
| Cash payments |
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||
| Balance at March 29, 2025 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Leases | Classification | March 29, 2025 | September 28, 2024 | |||||||||||
| Operating leases: | ||||||||||||||
| Operating lease right-of-use assets | Right-of-use asset | $ |
|
$ |
|
|||||||||
| Current operating lease liabilities |
Accrued expenses
|
|
|
|||||||||||
| Noncurrent operating lease liabilities | Operating lease liability |
|
|
|||||||||||
| Finance leases: | ||||||||||||||
| Finance lease right-of-use assets | Property, plant, and equipment, net | $ |
|
$ |
|
|||||||||
| Facility | Maturity Date | March 29, 2025 | September 28, 2024 | |||||||||||
| Revolving Credit Facility |
November 2029
|
$ |
|
$ |
|
|||||||||
| Term Loan | November 2031 |
|
|
|||||||||||
|
|
November 2031 |
|
|
|||||||||||
|
|
October 2029 |
|
|
|||||||||||
| Debt discounts, deferred fees and other |
(
|
|
||||||||||||
| Total long-term debt |
|
|
||||||||||||
| Current portion of long-term debt |
(
|
|
||||||||||||
| Long-term debt, less current portion | $ |
|
$ |
|
||||||||||
| Derivative Instruments | Hedge Designation | Balance Sheet Location | March 29, 2025 |
September 28, 2024
|
||||||||||||||||
| Cross-currency swaps | Designated | Other long-term liabilities | $ |
(
|
$ |
|
||||||||||||||
|
Quarterly Period Ended
|
Two Quarterly Periods Ended | ||||||||||||||||||||||||||||
| Derivative Instruments | Statements of Income Location | March 29, 2025 | March 30, 2024 | March 29, 2025 | March 30, 2024 | ||||||||||||||||||||||||
| Cross-currency swaps |
Interest expense
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
| March 29, 2025 | |||||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | Impairment | |||||||||||||||||||||||||
| Indefinite-lived trademarks | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Goodwill |
|
|
|
|
|
||||||||||||||||||||||||
| Definite lived intangible assets |
|
|
|
|
|
||||||||||||||||||||||||
| Property, plant, and equipment |
|
|
|
|
|
||||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| September 28, 2024 | |||||||||||||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | Impairment | |||||||||||||||||||||||||
| Indefinite-lived trademarks | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||
| Goodwill |
|
|
|
|
(
|
||||||||||||||||||||||||
| Definite lived intangible assets |
|
|
|
|
(
|
||||||||||||||||||||||||
| Property, plant, and equipment |
|
|
|
|
|
||||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
| Quarterly Period Ended | Two Quarterly Periods Ended | ||||||||||||||||||||||||||||||||||
| March 29, 2025 | March 30, 2024 | March 29, 2025 | March 30, 2024 | ||||||||||||||||||||||||||||||||
| Net Sales | |||||||||||||||||||||||||||||||||||
| Americas | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Rest of World |
|
|
|
|
|||||||||||||||||||||||||||||||
| Total net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Operating income (loss) | |||||||||||||||||||||||||||||||||||
| Americas | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Rest of World |
(
|
|
(
|
(
|
|||||||||||||||||||||||||||||||
| Total operating income (loss) | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Depreciation and amortization | |||||||||||||||||||||||||||||||||||
| Americas | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Rest of World |
|
|
|
|
|||||||||||||||||||||||||||||||
| Total depreciation and amortization | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Quarterly Period Ended | Two Quarterly Periods Ended | ||||||||||||||||||||||||||||||||||
| March 29, 2025 | March 30, 2024 | March 29, 2025 | March 30, 2024 | ||||||||||||||||||||||||||||||||
| Net Sales | |||||||||||||||||||||||||||||||||||
| United States and Canada | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Latin America |
|
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||
| Rest of World |
|
|
|
|
|||||||||||||||||||||||||||||||
| Total net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||
| Quarterly Period Ended | Two Quarterly Periods Ended | ||||||||||||||||||||||||||||||||||
| March 29, 2025 | March 30, 2024 | March 29, 2025 | March 30, 2024 | ||||||||||||||||||||||||||||||||
| Net Sales | |||||||||||||||||||||||||||||||||||
| Personal Care |
|
% |
|
% |
|
% |
|
% | |||||||||||||||||||||||||||
| Consumer Solutions |
|
% |
|
% |
|
% |
|
% | |||||||||||||||||||||||||||
| Quarterly Period Ended | Two Quarterly Periods Ended | ||||||||||||||||||||||||||||||||||
| (in millions, except share amounts) | March 29, 2025 | March 30, 2024 | March 29, 2025 | March 30, 2024 | |||||||||||||||||||||||||||||||
| Numerator | |||||||||||||||||||||||||||||||||||
| Consolidated net income (loss) | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Denominator | |||||||||||||||||||||||||||||||||||
| Weighted average common shares outstanding - basic and dilutive |
|
|
|
|
|||||||||||||||||||||||||||||||
| Quarter | Prior Quarter | $ Change | % Change | ||||||||||||||||||||
| Net sales | $ | 824 | $ | 558 | $ | 266 | 48 | % | |||||||||||||||
| Operating income | 4 | 21 | (17) | (81) | % | ||||||||||||||||||
| Quarter | Prior Quarter | $ Change | % Change | ||||||||||||||||||||
| Net sales | $ | 473 | $ | 375 | $ | 98 | 26 | % | |||||||||||||||
| Operating income | 8 | 20 | (12) | (60) | % | ||||||||||||||||||
| Quarter | Prior Quarter | $ Change | % Change | ||||||||||||||||||||
| Net sales | $ | 351 | $ | 183 | $ | 168 | 92 | % | |||||||||||||||
| Operating income (loss) | (4) | 1 | (5) | (500) | % | ||||||||||||||||||
| YTD | Prior YTD | $ Change | % Change | ||||||||||||||||||||
| Net sales | $ | 1,526 | $ | 1,077 | $ | 449 | 42 | % | |||||||||||||||
| Operating income (loss) | (18) | 9 | (27) | (300) | % | ||||||||||||||||||
| YTD | Prior YTD | $ Change | % Change | ||||||||||||||||||||
| Net sales | $ | 893 | $ | 723 | $ | 170 | 24 | % | |||||||||||||||
| Operating income | 1 | 17 | (16) | (94) | % | ||||||||||||||||||
| YTD | Prior YTD | $ Change | % Change | ||||||||||||||||||||
| Net sales | $ | 633 | $ | 354 | $ | 279 | 79 | % | |||||||||||||||
| Operating loss | (19) | (8) | (11) | 138 | % | ||||||||||||||||||
| March 29, 2025 | |||||
| Cash flow from operating activities | $ | 7 | |||
|
Pre-Transaction free cash flow from operating activities
(1)
|
90 | ||||
| Additions to property, plant and equipment | (39) | ||||
| Post-Transaction free cash flow | $ | 58 | |||
| Incorporated by reference to | ||||||||
| 10.1* | Amendment No. 1 to the Asset-Based Revolving Credit Agreement, dated November 4, 2024, by and among Treasure Holdco, Inc., Magnera Corporation, certain subsidiaries of Magnera, the lenders party thereto and Wells Fargo Bank, National Association as administrative agent, collateral agent and U.K. security trustee for the lenders. | |||||||
| 31.1* | ||||||||
| 31.2* | ||||||||
| 32.1** | ||||||||
| 32.2** | ||||||||
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data file because its iXBRL tags are embedded within the Inline XBRL document. | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema. | |||||||
| 101.CAL | Inline XBRL Extension Calculation Linkbase. | |||||||
| 101.DEF | Inline XBRL Extension Definition Linkbase. | |||||||
| 101.LAB | Inline XBRL Extension Label Linkbase. | |||||||
| 101.PRE | Inline XBRL Extension Presentation Linkbase. | |||||||
| 104 | Cover Page Interactive Data File (formatted as an inline XBRL and contained in Exhibit 101). | |||||||
|
Magnera Corporation
|
|||||||||||
| May 7, 2025 |
By:
|
/s/ James M. Till
|
|||||||||
|
James M. Till
|
|||||||||||
|
Chief Financial Officer
|
|||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|